1504-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫 episode artwork

EPISODE · Aug 28, 2026 · 22 MIN

1504-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫

from 聊聊Sci

这篇研究揭示了外周5-HT2AR受体在调节结直肠癌免疫反应中的关键作用。研究人员发现,经典致幻剂LSD能通过激活该受体增强CD8+ T细胞的抗肿瘤能力,但其致幻副作用限制了临床应用。为此,团队开发了不进入大脑的新型激动剂IHCH-8110,它能特异性激活肠道内的肠胶质细胞。这种激活促使细胞释放CXCL10和IL-18,从而招募并极化T细胞以攻击肿瘤。该化合物不仅能抑制癌症生长,还能使原本对免疫治疗不敏感的“冷肿瘤”产生反应,显著提升PD-1抑制剂的疗效。这一成果为结直肠癌的联合免疫治疗提供了无致幻风险的新策略。References:Wen Y T, Tang L J, Duan W W, et al. Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer[J]. Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Aug 28, 2026

Embed this episode

Ready to play

1504-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫

0:00 22:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 22 minutes long.

When was this 聊聊Sci episode published?

This episode was published on August 28, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!